Aspire BioPharma is trading at $8.35, up 7.33% during the October 13, 2026 session; no clear catalyst has been identified. - Its official press-release page lists no announcement dated October 13; the latest listed release is September 9, 2026. - Major U.S. indexes were nearly flat, and the available evidence does not establish a specific reason for the rise.